肝胆胰手术预防性补片放置与切口疝发生率:随机临床试验
该双盲随机临床试验在西班牙塞维利亚的Virgen Macarena医院开展,纳入具有2个及以上切口疝危险因素且计划行开放右肋下切口肝胆胰手术的患者,比较常规关腹与预防性合成补片加强关腹。结果显示,预防性补片显著降低12个月和24个月时的影像学切口疝发生率,且不增加术后并发症、手术部位事件或术后疼痛,补片组功能恢复更优;J形切口者切口疝发生率显著更高。
要点
- 对具有≥2个切口疝危险因素的开放右肋下肝胆胰手术患者,预防性合成补片关腹可显著降低切口疝发生率。
- 补片组与常规关腹组在术后并发症、手术部位事件及术后疼痛方面无差异,补片组功能恢复更优。
- J形切口患者的切口疝发生率显著高于Kocher切口,提示切口类型影响疝发生风险。
核心结论
- 预防性补片放置显著降低肝胆胰手术肋下切口术后切口疝的总体风险,且不增加术后并发症。
- 建议在肝胆手术肋下切口关腹时考虑放置合成补片以预防切口疝。
研究设计与样本
- 前瞻性、双盲随机临床试验,2020年7月至2024年12月在西班牙塞维利亚Virgen Macarena医院开展。
- 纳入具有2个及以上切口疝危险因素且计划行开放右肋下切口手术的患者,排除急诊手术、转移性疾病或术中确认不可切除的恶性肿瘤。
- 随机分为常规关腹组(n=69)与合成补片加强关腹组(n=75),排除5例符合术中排除标准者后,补片组66例、非补片组73例。
- 随访时间为术后1、3、6、12和24个月。
- 主要结局为12至24个月后的影像学切口疝;次要结局包括切口类型(Kocher或J形)、术后并发症、手术部位事件、术后疼痛和功能恢复。
主要发现
- 12个月随访时,补片组57例、非补片组60例可分析,影像学切口疝发生率分别为5.2%和21%,补片组显著降低。
- 24个月随访时,补片组49例、非补片组48例可分析,影像学切口疝发生率非补片组为37.5%(18例),补片组为8.1%(4例),非补片组显著增高。
- 两组在手术部位事件、术后并发症或术后疼痛方面未见差异。
- 补片组患者功能恢复显著改善。
- J形切口者的切口疝发生率显著更高。
临床怎么用
- 对具有2个及以上切口疝危险因素、计划行开放右肋下切口肝胆胰手术的患者,可考虑在关腹时预防性放置合成补片以降低切口疝风险。
- 选择切口类型时需注意J形切口与更高的切口疝发生率相关。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: The incidence of incisional hernia after hepatobiliopancreatic surgery could reach 40%. There is a lack of evidence regarding the use of prophylactic mesh in subcostal incisions. OBJECTIVE: To evaluate whether prophylactic mesh placement during abdominal wall closure reduces the rate of incisional hernias. DESIGN, SETTING, AND PARTICIPANTS: This prospective, double-blinded randomized clinical trial was conducted between July 2020 and December 2024 at Virgen Macarena Hospital in Seville, Spain. Patients with 2 or more risk factors for incisional hernias and scheduled for open right subcostal access were considered. Exclusion criteria included emergency surgery, metastatic disease, or unresectable malignant neoplasm identified during the surgery. Follow-up was at 1, 3, 6, 12, and 24 months, postoperatively. INTERVENTION: Conventional abdominal wall closure vs conventional closure with prophylactic synthetic mesh placement. MAIN OUTCOMES AND MEASURES: The primary outcome measure was radiological incisional hernia after 12 to 24 months. Secondary outcomes included incision type (Kocher or J incision), postoperative complications, surgical site occurrences rate, postoperative pain, and functional recovery. RESULTS: There were 144 patients randomized to either conventional closure (n = 69) or synthetic mesh-reinforced closure (n = 75); after 5 patients were excluded because of intraoperative exclusion criteria, 66 patients were assigned to the mesh group and 73 patients to the nonmesh group. At 12-month follow-up, 57 patients in the mesh group and 60 in the nonmesh group were analyzed; 5.2% of patients in the mesh group and 21% in the nonmesh group showed a radiological incisional hernia, with a significant reduction of incisional hernia rate. After 24 months of follow-up, 49 patients in the mesh group and 48 patients in the nonmesh group were analyzed; radiological incisional hernia rate was significantly increased in no-mesh group with 18 (37.5%) patients and 4 (8.1%) patients in mesh group. No differences in surgical site occurrences, postoperative complications, or postoperative pain were identified between the groups. Patients in the mesh group showed significant improvement in functional recovery. This study showed a significantly higher incisional hernia rate when a J incision was performed. CONCLUSIONS AND RELEVANCE: This randomized clinical trial found that prophylactic mesh placement significantly reduced the overall risk of incisional hernia after hepatobiliary incisions without increasing postoperative complications. These results suggest that to prevent incisional hernias after hepatobiliary surgery through a subcostal incision, the placement of a synthetic mesh during abdominal wall closure should be considered. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT07433439.
引用
- Bellido-Luque J, Sanchez-Matamoros Martín I, Reguera-Rosal J, et al. Prophylactic Mesh Placement and Incisional Hernia Incidence in Hepatobiliopancreatic Surgery: A Randomized Clinical Trial. JAMA Surg. 2026. PMID: 42714891. doi:10.1001/jamasurg.2026.4012
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。